Small intestinal motility

Current Opinion in Gastroenterology

Volumn 22, Issue 2, 2006, Pages 111-116

  Jones, Michael P ^a,b   Wessinger, Sarah ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Galter Pavilion 4 104 ^*  (United States)

Author keywords

Ileus; Motility; Pseudoobstruction; Small intestine

Indexed keywords

ALVIMOPAN; CANNABINOID RECEPTOR; CARAWAY OIL; CISAPRIDE; GASTROINTESTINAL HORMONE; NEUROTRANSMITTER; OPIATE ANTAGONIST; PEPPERMINT OIL; PEPTIDE; RIMONABANT; SCOPOLAMINE; SUMATRIPTAN; UNCLASSIFIED DRUG; VEGETABLE OIL;

BACTERIAL GROWTH; BEHAVIOR; HUMAN; IDIOPATHIC DISEASE; ILEUS; INFLAMMATION; INTERSTITIAL CELL OF CAJAL; INTESTINAL DYSMOTILITY; INTESTINE FLORA; INTESTINE INFECTION; INTESTINE MOTILITY; INTESTINE PSEUDOOBSTRUCTION; IRRITABLE COLON; MEDICAL INFORMATICS; NONHUMAN; POSTOPERATIVE COMPLICATION; REVIEW; SENSATION; SMALL INTESTINE; STRESS; GASTROINTESTINAL MOTILITY; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR;

GASTROINTESTINAL MOTILITY; HUMANS; INTESTINAL PSEUDO-OBSTRUCTION; INTESTINE, SMALL; RISK FACTORS;

EID: 33646443037     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mog.0000203867.33008.52     Document Type: Review

References (46)

1. Vanderwinden JM, Rumessen JJ. Interstitial cells of Cajal in human gut and gastrointestinal disease. Microsc Res Tech 1999; 47:344-360.
2. Ördög T, Redelman D, Horvath VJ, et al. Quantitative analysis by flow cytometry of interstitial cells of Cajal, pacemakers, and mediators of neurotransmission in the gastrointestinal tract. Cytometry A 2004; 62:139-149. Novel application of flow cytometry to identify ICC cells from murine tissue and cell culture.
3. Lyford GL, He CL, Soffer E, et al. Pan-colonic decrease in interstitial cells of Cajal in patients with slow transit constipation. Gut 2002; 51:496-501.
4. Pardi DS, Miller SM, Miller DL, et al. Paraneoplastic dysmotility: loss of interstitial cells of Cajal. Am J Gastroenterol 2002; 97:1828-1833.
5. Lee JI, Park H, Kamm MA, Talbot IC. Decreased density of interstitial cells of Cajal and neuronal cells in patients with slow-transit constipation and acquired megacolon. J Gastroenterol Hepatol 2005; 20:1292-1298.
6. Grotz RL, Pemberton JH, Talley NJ, et al. Discriminant value of psychological distress, symptom profiles, and segmental colonic dysfunction in outpatients with severe idiopathic constipation. Gut 1994; 35:798-802.
7. Kamm MA. Role of surgical treatment in patients with severe constipation. Ann Med 1990; 22:435-442.
8. Devroede G, Girard G, Bouchoucha M, et al. Idiopathic constipation by colonic dysfunction: relationship with personality and anxiety. Dig Dis Sci 1989; 34:1428-1433.
9. Glia A, Akerlund JE, Lindberg G. Outcome of colectomy for slow-transit constipation in relation to presence of small-bowel dysmotility. Dis Colon Rectum 2004; 47:96-102. Although the sample size is small, the authors demonstrate the importance of assessing small intestinal motility prior to colectomy for constipation.
10. Scott SM, Picon L, Knowles CH, et al. Automated quantitative analysis of nocturnal jejunal motor activity identifies abnormalities in individuals and subgroups of patients with slow transit constipation. Am J Gastroenterol 2003; 98:1123-1134.
11. Langer JC. Persistent obstructive symptoms after surgery for Hirschsprung's disease: development of a diagnostic and therapeutic algorithm. J Pediatr Surg 2004; 39:1458-1462. Report on a large number of patients with symptoms after surgery to treat Hirschsprung's disease. Findings from these evaluations inform recommendations on the evaluation of these patients.
12. Stanghellini V, Cogliandro RF, De Giorgio R, et al. Natural history of chronic idiopathic intestinal pseudo-obstruction in adults: a single center study. Clin Gastroenterol Hepatol 2005; 3:449-458. This large, extensively evaluated series of patients with CIIP provides important information regarding the evaluation and natural history of this rare condition.
13. Knowles CH, Silk DB, Darzi A, et al. Deranged smooth muscle alpha-actin as a biomarker of intestinal pseudo-obstruction: a controlled multinational case series. Gut 2004; 53:1583-1589. α-Actin expression may be a useful biomarker in the identification of a subset of patients with CIIP although its pathophysiologic significance requires explanation.
14. Weston S, Thumshirn M, Wiste J, Camilleri M. Clinical and upper gastrointestinal motility features in systemic sclerosis and related disorders. Am J Gastroenterol 1998; 93:1085-1089.
15. D'Angelo WA, Fries JF, Masi AT, Shulman LE. Pathologic observations in systemic sclerosis (scleroderma): a study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med 1969; 46:428-440.
16. Pedersen J, Gao C, Egekvist H, et al. Pain and biomechanical responses to distention of the duodenum in patients with systemic sclerosis. Gastroenterology 2003; 124:1230-1239.
17. Gunnarsdottir SA, Sadik R, Shev S, et al. Small intestinal motility disturbances and bacterial overgrowth in patients with liver cirrhosis and portal hypertension. Am J Gastroenterol 2003; 98:1362-1370.
18. Soza A, Riquelme A, Gonzalez R, et al. Increased orocecal transit time in patients with nonalcoholic fatty liver disease. Dig Dis Sci 2005; 50:1136-1140.
19. Strid H, Simren M, Stotzer PO, et al. Patients with chronic renal failure have abnormal small intestinal motility and a high prevalence of small intestinal bacterial overgrowth. Digestion 2003; 67:129-137.
20. Pimentel M, Chow EJ, Lin HC. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol 2000; 95:3503-3506.
21. Pimentel M, Chow EJ, Lin HC. Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome: a double-blind, randomized, placebo-controlled study. Am J Gastroenterol 2003; 98:412-419.
22. Pimentel M, Constantino T, Kong Y, et al. A 14-day elemental diet is highly effective in normalizing the lactulose breath test. Dig Dis Sci 2004; 49:73-77.
23. Riordan SM, McIver CJ, Walker BM, et al. The lactulose breath hydrogen test and small intestinal bacterial overgrowth. Am J Gastroenterol 1996; 91: 1795-1803.
24. Walters B, Vanner SJ. Detection of bacterial overgrowth in IBS using the lactulose H2 breath test: comparison with 14C-D-xylose and healthy controls. Am J Gastroenterol 2005; 100:1566-1570. Another study nicely pointing out the shortcomings of the lactulose breath test in diagnosing small intestinal bacterial overgrowth.
25. Porras M, Martin MT, Soler M, Vergara P. Intestinal motor disorders associated with cyclical bacterial overgrowth in a rat model of enteritis. Am J Physiol Gastrointest Liver Physiol 2004; 287:G58-G64.
26. Bercik P, Wang L, Verdu EF, et al. Visceral hyperalgesia and intestinal dysmotility in a mouse model of postinfective gut dysfunction. Gastroenterology 2004; 127:179-187.
27. Verdu EF, Bercik P, Bergonzelli GE, et al. Lactobacillus paracasei normalizes muscle hypercontractility in a murine model of postinfective gut dysfunction. Gastroenterology 2004; 127:826-837.
28. la Fleur SE, Wick EC, Idumalla PS, et al. Role of peripheral corticotropin-releasing factor and urocortin II in intestinal inflammation and motility in terminal ileum. Proc Natl Acad Sci U S A 2005; 102:7647-7652.
29. Martinez V, Wang L, Rivier J, et al. Central CRF, urocortins and stress increase colonic transit via CRF1 receptors while activation of CRF2 receptors delays gastric transit in mice. J Physiol 2004; 556:221-234.
30. Teresa Martin M, Azpiroz F, Malagelada JR. Melatonin as a modulator of the ileal brake mechanism. Scand J Gastroenterol 2005; 40:559-563. The role of melatonin in modulating the ileal brake is nicely demonstrated using melatonin and melatonin antagonists.
31. Jahovic N, Sener G, Cevik H, et al. Amelioration of methotrexate-induced enteritis by melatonin in rats. Cell Biochem Funct 2004; 22:169-178.
32. Song GH, Leng PH, Gwee KA, et al. Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances: a randomised, double blind, placebo controlled study. Gut 2005; 54:1402-1407. Melatonin improved IBS symptoms but not sleep disturbances in these sleep-disturbed IBS patients.
33. Goerg KJ, Spilker T. Effect of peppermint oil and caraway oil on gastrointestinal motility in healthy volunteers: a pharmacodynamic study using simultaneous determination of gastric and gall-bladder emptying and orocaecal transit time. Aliment Pharmacol Ther 2003; 17:445-451.
34. Boeckxstaens GE, Hirsch DP, Kuiken SD, et al. The proximal stomach and postprandial symptoms in functional dyspeptics. Am J Gastroenterol 2002; 97:40-48.
35. Tack J, Piessevaux H, Coulie B, et al. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 1998; 115:1346-1352.
36. 1 agonist as a therapeutic agent to treat dyspepsia.
37. Yanagida H, Yanase H, Sanders KM, Ward SM. Intestinal surgical resection disrupts electrical rhythmicity, neural responses, and interstitial cell networks. Gastroenterology 2004; 127:1748-1759. Very nicely performed study demonstrating the physiologic and histologic effects of surgical resection on intestinal neurophysiology.
38. Schwarz NT, Kalff JC, Turler A, et al. Selective jejunal manipulation causes postoperative pan-enteric inflammation and dysmotility. Gastroenterology 2004; 126:159-169. Well performed experiment showing that local intestinal manipulation in rats results in altered motility at remote sites in the digestive tract. The molecular and cellular changes associated with this 'field effect' are nicely demonstrated.
39. de Jonge WJ, van den Wijngaard RM, The FO, et al. Postoperative ileus is maintained by intestinal immune infiltrates that activate inhibitory neural pathways in mice. Gastroenterology 2003; 125:1137-1147.
40. Mascolo N, Izzo AA, Ligresti A, et al. The endocannabinoid system and the molecular basis of paralytic ileus in mice. FASEB J 2002; 16:1973-1975.
41. Basse L, Madsen JL, Billesbolle P, et al. Gastrointestinal transit after laparoscopic versus open colonic resection. Surg Endosc 2003; 17: 1919-1922.
42. Chen JY, Wu GJ, Mok MS, et al. Effect of adding ketorolac to intravenous morphine patient-controlled analgesia on bowel function in colorectal surgery patients: a prospective, randomized, double-blind study. Acta Anaesthesiol Scand 2005; 49:546-551.
43. Delaney CP, Weese JL, Hyman NH, et al. Phase III trial of alvimopan, a novel, peripherally acting, mu opioid antagonist, for postoperative ileus after major abdominal surgery. Dis Colon Rectum 2005; 48:1114-1125; discussion 1125-1126; author reply 1127-1129. Well designed trial demonstrating the efficacy of a peripheral opiate antagonist in improving outcomes for POI.
44. Shafik A, Shafik AA, el-Sibai O. Study of the effect of jejuno-ileal distension on the motor activity of the stomach with evidence of 'entero-gastric inhibitory reflex'. Hepatogastroenterology 2003; 50:1966-1969.
45. Shafik A, Shafik AA, Ahmed I. Effect of colonic distention on ileal motor activity with evidence of coloileal reflex. J Gastrointest Surg 2003; 7:701-705.
46. Coremans G, Geypens B, Vos R, et al. Influence of continuous isobaric rectal distension on gastric emptying and small bowel transit in young healthy women. Neurogastroenterol Motil 2004; 16:107-111.